Molecular Staging

About:

Molecular Staging is a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids.

Website: https://www.molecularstaging.com/

Top Investors: OrbiMed, Domain Associates, Investor Growth Capital Limited, CIBC Capital Partners, CHL Medical Partners

Description:

Molecular Staging, Inc., a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids. It provides technologies for proteomics, genomics, pharmacogenomics, and diagnostics applications. The company’s products and services include protein microarrays analogous to the DNA microarray, enabling researchers to study multiple proteins; whole-genome amplification that allows DNA samples as resources, enabling researchers to return to them for new tests or confirmatory diagnoses; and multiplexed diagnostics that enable earlier detection of disease.

Total Funding Amount:

$41.3M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

1998-01-01

Founders:

Number of Employees:

101-250

Last Funding Date:

2003-02-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai